Armed with the synergistic expertise and strategic specimens needed, we aim to decipher the molecular landscape for metastatic esophageal tumors utilizing matched primary tumors and their metastatic lymph node tumors, as well as liquid biopsies.
The rare circulating tumor cells (CTCs) in the blood, which are the “seeds” for metastasis, offer the opportunity for non-invasive real-time monitoring of cancers to capture the molecular heterogeneity evolving in drug-resistant tumors under selective treatment pressure and to more accurately reflect tumor heterogeneity that may be missed from the original tumor tissues.
These e-fuels can be stored indefinitely without quality degradation and transported to wherever needed safely and easily.
The electricity generated by e-fuel cells can be integrated into the grid.
Our current research focuses on these skeletal disorders and injuries with limited repair and healing potential, including osteoporotic fracture, avascular osteoneocrosis (AVN) around joints with extremely high incidence of OA, and tendon-bone insertion reconstruction.
Therefore, our collaborative and multidisciplinary research focuses on enhancing treatment outcome of these skeletal disorders or injuries by augmenting the regenerative potential of autologous BMSCs and mobilizing circulating stem cells to bone defects for bone regeneration.Yet it is a persistent problem in many urban areas, together with other photochemical pollutants including secondary organic aerosol (SOA).